Chronic kidney disease (CKD) is associated with alterations of the gut microbiome, sometimes referred to as dysbiosis. These changes may include reductions in the bacterial species involved in SCFA production and increases in bacterial enzymes involved in the production of uremic toxins (substances that can build up in the body of people with CKD).[1] Because of this, RS has been a supplement of interest given its ability to modulate the microbiome and increase the production of SCFAs in some people. In a 2022 meta-analysis of randomized controlled trials, RS supplementation was found to reduce blood levels of indoxyl sulfate (a uremic toxin associated with worse health outcomes in CKD),[2] phosphorus, interleukin-6, and uric acid in people with CKD undergoing dialysis.[3] While this is promising, it is unclear whether these beneficial effects lead to any meaningful changes in health outcomes, and further research is required.
Is resistant starch beneficial in chronic kidney disease?
Written by:
Fact-checked
by:
•Last Updated: April 23, 2025
Resistant starch may benefit people with chronic kidney disease by modulating the gut microbiome and increasing short-chain fatty acid production, which can reduce levels of harmful uremic toxins and other substances. However, it remains uncertain whether these effects translate into significant health improvements, which necessitates further research.